CCC is back in business under O’Brien
Shannon O’Brien is back at the helm at the Cannabis Control Commission and kicked off her second run as chair with a commitment to collaboration.
Aurora Cannabis: President Trump’s Video Changes Nothing
Discover how Aurora Cannabis Inc.’s turnaround and Trump’s CBD remarks impact its stock, plus new risks to watch for. Click here to read why ACB is a Sell.
Feds Call Marijuana A ‘Deadly’ Drug And Say Even Medical Cannabis Has ‘Serious Consequences’
Federal officials are calling marijuana a “deadly” drug—touting their efforts to seize it and other illegal substances—while also warning that possessing cannabis, even for medical use, carries …
Detroit marijuana grower loses license after numerous issues identified inside facility
Cherry Industries LLC could not account for 4,200 pounds of product that had been recorded in the statewide monitoring system, while more than 41,000 pounds was never entered.
Cannabis business owners fume as medical pot companies jump first into recreational market
Minnesota cannabis entrepreneurs say they are confused and angry after the two companies that serve patients in the state’s medical marijuana program were allowed to immediately start selling …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Trump Orders the ‘Expeditious’ Reclassification of Marijuana
On Thursday, President Donald Trump delivered on his promise to proceed with the reclassification of marijuana under the Controlled Substances Act, a long-awaited step that recognizes the drug does …
Cloud lifts over cannabis companies’ future amid push to reclassify the drug
NEW YORK — Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald Trump’s move to help reclassify the drug’s status. The companies …
Trump reignites marijuana stock rally; signs executive order to urge drug reclassification
Marijuana stocks generally reversed lower, after a nearly week-long rally, in Thursday’s stock market after President Donald Trump signed an executive order to hasten federal reclassification of …
Why Curaleaf Holdings Stock Popped by Almost 25% on Tuesday
Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Image source: . Trump stated that he was “considering it, yeah,” …
Smoke and mirrors in cannabis zoning
In New Orleans, marijuana dispensaries — like the one opening soon in our community can be granted a permit without any neighborhood notice. And in Louisiana, unlike other neighboring states, …
Whitmer’s 24% cannabis tax plan alarms struggling industry
While Whitmer and state lawmakers target the cannabis industry, legislators have not touched the 4% liquor tax since it was set in 1985. That may be because the liquor industry has one of the most …
Albert Lea broke city ordinance during cannabis fight, judge rules
A recent judge ruling says that Albert Lea city officials broke their own rules when they denied a business license to the first retailer licensed in Minnesota due in part to concerns over a past …
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.
A drug made from marijuana reduced back pain in a large study
WASHINGTON — An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms …
Recent Comments